-
公开(公告)号：EP4065583A1
公开(公告)日：2022-10-05
申请号：EP20833977.0
申请日：2020-11-27
发明人： KAWAI, Yuichi , SHIBATA, Kazuaki , ASAKURA, Hiroki , UNO, Takao , SAGARA, Takeshi , NAKAMURA, Masayuki , KOBAYAKAWA, Yu , HOLVEY, Rhian, Sara
IPC分类号： C07D487/08 , C07D491/04 , A61P35/00 , A61K31/519
-
公开(公告)号：EP4347041A1
公开(公告)日：2024-04-10
申请号：EP22738053.2
申请日：2022-05-27
发明人： KOBAYAKAWA, Yu , OSHIMA, Tsuyoshi , ITO, Satoru , SCHÖPF, Patrick
IPC分类号： A61P35/00 , C07D487/04 , C07D519/00 , A61K31/541 , A61K31/519 , A61K31/554 , A61K31/55 , A61K31/553
-
3.发明公开
公开(公告)号：EP3988173A1
公开(公告)日：2022-04-27
申请号：EP20825777.4
申请日：2020-06-17
IPC分类号： A61P35/00 , C07H19/14 , A61K31/7064
摘要： There is provided a novel phosphate ester compound having a pyrrolopyrimidine skeleton having an excellent antitumor effect or a pharmaceutically acceptable salt thereof, and a method for preventing and/or treating a tumor in combination with an alkylating agent and/or a radiation therapy. According to one aspect of the present invention, there is provided a compound represented by the following general formula (1) or a pharmaceutically acceptable salt thereof, and a method for preventing and/or treating a tumor in combination with an alkylating agent and/or a radiation therapy.
-
公开(公告)号：EP4436571A1
公开(公告)日：2024-10-02
申请号：EP22899518.9
申请日：2022-11-22
发明人： SLOMAN, David L. , GATHIAKA, Symon , KAWAMURA, Shuhei , HENDERSON, Timothy , HOOVER, Andrew J. , SWAMINATHAN, Uma , BHARATHAN, Indu , GRAHAM, Thomas H. , HAN, Yongxin , SCHÖPF, Patrick , KOBAYAKAWA, Yu , OSHIMA, Tsuyoshi , UNO, Takao
IPC分类号： A61K31/33 , A61K31/395 , A61K31/495 , A61K31/505
CPC分类号： A61K45/06 , C07D401/14 , C07D487/04 , C07D401/04 , C07D471/04 , C07D519/00 , C07D417/14
-
-
-
搜索结果
4 条记录 (耗时 0.013 秒)
